GlassScriptPhysician profile
Edward K Isbey
NPI 1154302560
$627.43
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $37.37 · 2021: $82.44 · 2022: $239.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $280.18 | 2019-2022 | |
| Horizon Therapeutics Plc | $99.11 | 2019-2020 | |
| Omeros Corporation | $57.17 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $41.21 | 2019 | |
| Novartis Pharmaceuticals Corporation | $41.05 | 2019-2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Rxsight INC | $18.74 | 2022 | |
| Allergan, INC. | $16.24 | 2019 | |
| Abbvie INC. | $15.74 | 2022 | |
| Sight Sciences, INC. | $14.06 | 2022 | |
| Ocular Therapeutix, INC. | $13.69 | 2019 | |
| Dompe US, INC. | $10.84 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Isbey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.